title: Short-term acetaminophen consumption enhances the exercise-induced increase in Achilles peritendinous IL-6 in humans.
abstract: Through an unknown mechanism, the cyclooxygenase inhibitor and antipyretic acetaminophen (APAP) alters tendon mechanical properties in humans when consumed during exercise. Interleukin-6 (IL-6) is produced by tendon during exercise and is a potent stimulator of collagen synthesis. In nontendon tissue, IL-6 is upregulated in the presence of cyclooxygenase inhibitors and may contribute to alterations in extracellular matrix turnover, possibly due to inhibition of prostaglandin E2 (PGE2). We evaluated the effects of APAP on IL-6 and PGE2 in human Achilles peritendinous tissue after 1 h of treadmill exercise. Subjects were randomly assigned to a placebo (n = 8, 26 ± 1 yr) or APAP (n = 8, 25 ± 1 yr) group. Each subject completed a nonexercise and exercise experiment consisting of 6 h of microdialysis. Drug (APAP, 1,000 mg) or placebo was administered in a double-blind manner during both experiments. PGE2 and IL-6 were determined via enzyme immunoassay and APAP via high-performance liquid chromatography. In subjects given APAP, peritendinous APAP levels increased to 4.08 ± 0.65 μg/ml (P < 0.05). PGE2 did not increase with exercise in either group (P > 0.05), nor was PGE2 significantly reduced in the APAP group. IL-6 levels increased with exercise in both groups (P < 0.05), but this increase was greater in the APAP group (P < 0.05). Our findings suggest that APAP enhances tendon IL-6 production after exercise. Peak levels of APAP obtained in the peritendinous space were twofold lower than values reported in plasma or skeletal muscle. These findings provide insight into the effects of APAP on tendon and provide novel information on the kinetics of APAP in tendon tissue after oral APAP consumption.
authors.affiliation: 1Department of Physiology, Arizona College of Osteopathic Medicine, Midwestern University, Glendale, Arizona;
authors.forename: Brian S
authors.initials: BS
authors.lastname: Gump
authors.forename: David R
authors.initials: DR
authors.lastname: McMullan
authors.forename: David J
authors.initials: DJ
authors.lastname: Cauthon
authors.forename: Jamie A
authors.initials: JA
authors.lastname: Whitt
authors.forename: Jonathon D
authors.initials: JD
authors.lastname: Del Mundo
authors.forename: Tanya
authors.initials: T
authors.lastname: Letham
authors.forename: Paul J
authors.initials: PJ
authors.lastname: Kim
authors.forename: Gary N
authors.initials: GN
authors.lastname: Friedlander
authors.forename: Jessica
authors.initials: J
authors.lastname: Pingel
authors.forename: Henning
authors.initials: H
authors.lastname: Langberg
authors.forename: Chad C
authors.initials: CC
authors.lastname: Carroll
mesh_terms: D000082:Acetaminophen / Q000008:administration & dosage* / Q000493:pharmacokinetics; D000125:Achilles Tendon / Q000187:drug effects* / Q000502:physiology*; D000284:Administration, Oral; D000328:Adult; D052246:Cyclooxygenase 2 Inhibitors / Q000008:administration & dosage / Q000493:pharmacokinetics; D015232:Dinoprostone / Q000378:metabolism; D004311:Double-Blind Method; D015444:Exercise / Q000502:physiology; D005260:Female; D006801:Humans; D015850:Interleukin-6 / Q000096:biosynthesis*; D008297:Male; D017551:Microdialysis; D055815:Young Adult
chemical_list: D052246:Cyclooxygenase 2 Inhibitors; C508600:IL6 protein, human; D015850:Interleukin-6; D000082:Acetaminophen; D015232:Dinoprostone
keywords: acetaminophen; cytokine; exercise; paracetomol; tendon